Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 14, 2019

BUY
$14.62 - $22.13 $4.71 Million - $7.14 Million
322,500 New
322,500 $6.79 Million
Q1 2018

May 14, 2018

SELL
$24.4 - $40.25 $2.93 Million - $4.83 Million
-120,000 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$18.5 - $28.6 $2.02 Million - $3.13 Million
-109,278 Reduced 47.66%
120,000 $0
Q3 2017

Nov 14, 2017

BUY
$14.65 - $19.35 $3.36 Million - $4.44 Million
229,278
229,278 $4.44 Billion

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $583M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.